Abbott's $5.8 Billion Deal for Alere Is Device Sector's LatestBy
Stryker, Medtronic also announced medical device deals Monday
CEO says Abbott has appetite for acquisitions in other areas
Abbott Laboratories agreed to buy Alere Inc. for $56 a share, or about $5.8 billion, to become the leader in the market for rapid medical tests and adding another deal to a long list in the fast-consolidating medical devices and technology space.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.